BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, Wiesner T, Rodríguez-Peralto JL, Requena L, Torrelo A. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 2020;183:729-37. [PMID: 32562567 DOI: 10.1111/bjd.19327] [Cited by in Crossref: 179] [Cited by in F6Publishing: 158] [Article Influence: 89.5] [Reference Citation Analysis]
Number Citing Articles
1 Cavazos A, Deb A, Sharma U, Nugent K. COVID toes following vaccination. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2043732] [Reference Citation Analysis]
2 Ricke DO. Models for SARS-CoV-2 associated thrombocytopenia associated with hemophagocytic histiocytes. Med Hypotheses 2021;157:110700. [PMID: 34673371 DOI: 10.1016/j.mehy.2021.110700] [Reference Citation Analysis]
3 Azar G, Bonnin S, Vasseur V, Faure C, Salviat F, Clermont CV, Titah C, Farès S, Boulanger E, Derrien S, Couturier A, Duvilliers A, Manassero A, Hage R, Tadayoni R, Behar-Cohen F, Mauget-Faÿsse M. Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? J Clin Med 2021;10:5038. [PMID: 34768555 DOI: 10.3390/jcm10215038] [Reference Citation Analysis]
4 Van Wert M, Ghio M, Graham C, Smetherman D, Sanders R, Corsetti R. Multicentric Breast Abscesses in a Patient Who Had COVID-19. Ochsner J 2021;21:402-5. [PMID: 34984056 DOI: 10.31486/toj.21.0095] [Reference Citation Analysis]
5 Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol 2021;46:444-50. [PMID: 33180982 DOI: 10.1111/ced.14481] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Caselli D, Chironna M, Loconsole D, Aricò M. Response to 'No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain'. Reply from the authors. Br J Dermatol 2020;183:1156-7. [PMID: 32974916 DOI: 10.1111/bjd.19563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Welsh E, Cardenas-de la Garza JA, Cuellar-Barboza A, Franco-Marquez R, Arvizu-Rivera RI. SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19. Br J Dermatol 2021;184:1194-5. [PMID: 33511657 DOI: 10.1111/bjd.19833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Brumfiel CM, DiLorenzo AM, Petronic-Rosic VM. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children. Clin Dermatol 2021;39:329-33. [PMID: 34272031 DOI: 10.1016/j.clindermatol.2020.10.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Cassius C, Merandet M, Frumholtz L, Bergerat D, Samri A, Grolleau C, Grzelak L, Schwartz O, Yatim N, Moghadam P, Jaume L, Bagot M, Legoff J, Delaugerre C, Bouaziz JD, Le Buanec H; Saint-Louis CORE (COvid Research). Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic. Br J Dermatol 2021. [PMID: 34258762 DOI: 10.1111/bjd.20647] [Reference Citation Analysis]
10 Abdullaev A, Odilov A, Ershler M, Volkov A, Lipina T, Gasanova T, Lebedin Y, Babichenko I, Sudarikov A. Viral Load and Patterns of SARS-CoV-2 Dissemination to the Lungs, Mediastinal Lymph Nodes, and Spleen of Patients with COVID-19 Associated Lymphopenia. Viruses 2021;13:1410. [PMID: 34372615 DOI: 10.3390/v13071410] [Reference Citation Analysis]
11 Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
12 López-Sundh AE, Gómez-Fernández C, González-López MA. Reader Comment Regarding "Approach to Chilblains During the COVID-19 Pandemic". J Cutan Med Surg 2021;25:342-3. [PMID: 33624512 DOI: 10.1177/1203475421997355] [Reference Citation Analysis]
13 Gkoutzourelas A, Bogdanos DP, Sakkas LI. Kawasaki Disease and COVID-19. Mediterr J Rheumatol 2020;31:268-74. [PMID: 33196004 DOI: 10.31138/mjr.31.3.268] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
14 McMurray JC, May JW, Cunningham MW, Jones OY. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment. Front Pediatr 2020;8:626182. [PMID: 33425823 DOI: 10.3389/fped.2020.626182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
15 Watanabe H, Ashida M, Satomi N, Koike Y, Kuwatsuka S, Murota H. Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell. J Dermatol 2022. [PMID: 35373396 DOI: 10.1111/1346-8138.16374] [Reference Citation Analysis]
16 Castelo-Soccio L, Lara-Corrales I, Paller AS, Bean E, Rangu S, Oboite M, Flohr C, Ahmad RC, Calberg V, Gilliam A, Pope E, Reynolds S, Sibbald C, Shin HT, Berger E, Schaffer J, Siegel MP, Cordoro KM. Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA). Pediatr Dermatol 2021;38:364-70. [PMID: 33742457 DOI: 10.1111/pde.14566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kolivras A, Thompson C, Pastushenko I, Mathieu M, Bruderer P, de Vicq M, Feoli F, Harag S, Meiers I, Olemans C, Sass U, Dehavay F, Fakih A, Lam-Hoai XL, Marneffe A, Van De Borne L, Vandersleyen V, Richert B. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. J Cutan Pathol 2021. [PMID: 34272741 DOI: 10.1111/cup.14099] [Reference Citation Analysis]
18 Yıldırım Bay E, Moustafa E, Semiz Y, Gündoğdu O, Oguz Topal I, Yalçın Ö. Leukocytoclastic vasculitis secondary to COVID-19 infection presenting with inclusion bodies: A histopathological correlation. J Cosmet Dermatol 2022;21:27-9. [PMID: 34846786 DOI: 10.1111/jocd.14637] [Reference Citation Analysis]
19 Fortini F, Vieceli Dalla Sega F, Marracino L, Severi P, Rapezzi C, Rizzo P, Ferrari R. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 2021;9:997. [PMID: 34440201 DOI: 10.3390/biomedicines9080997] [Reference Citation Analysis]
20 Andina D, Colmenero I, Santonja C, Muñoz de León I, Noguera-Morel L, Hernández-Martín A, Torrelo A. Suspected COVID-19-related reticulated purpura of the soles in an infant. Pediatr Dermatol 2021;38:301-3. [PMID: 33085141 DOI: 10.1111/pde.14409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Strauss SA, Seo C, Carrier M, Jetty P. From cellular function to global impact: the vascular perspective on COVID-19. Can J Surg 2021;64:E289-97. [PMID: 33978563 DOI: 10.1503/cjs.023820] [Reference Citation Analysis]
22 Atzori L, Ferreli C, Mateeva V, Vassileva S, Rongioletti F. Clinicopathologic features between different viral epidemic outbreaks involving the skin. Clin Dermatol 2021;39:405-17. [PMID: 34517998 DOI: 10.1016/j.clindermatol.2021.04.002] [Reference Citation Analysis]
23 Kaya G, Kaya A, Saurat JH. Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature. Dermatopathology (Basel). 2020;7:3-16. [PMID: 32608380 DOI: 10.3390/dermatopathology7010002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
24 Dalan R, Boehm BO. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective. Diabetes Metab Res Rev 2021;37:e3402. [PMID: 32871617 DOI: 10.1002/dmrr.3402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Sridhar S, Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology 2021;26:652-65. [PMID: 34041821 DOI: 10.1111/resp.14091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Soy M, Keser G, Atagündüz P. Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol 2021;45:372-89. [PMID: 34803441 DOI: 10.3906/biy-2105-37] [Reference Citation Analysis]
27 Fan BE, Cheung C. Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger. Semin Thromb Hemost 2021. [PMID: 33860515 DOI: 10.1055/s-0041-1728717] [Reference Citation Analysis]
28 Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021;17:315-32. [PMID: 33903743 DOI: 10.1038/s41584-021-00608-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
29 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
30 Kopacz A, Ludwig C, Tarbox M. Atypical cutaneous and musculoskeletal manifestation of SARS-CoV-2: 'COVID-19 toes' and spasticity in a 48-year-old woman. BMJ Case Rep 2021;14:e241410. [PMID: 33731393 DOI: 10.1136/bcr-2020-241410] [Reference Citation Analysis]
31 Shaw RJ, Bradbury C, Abrams ST, Wang G, Toh CH. COVID-19 and immunothrombosis: emerging understanding and clinical management. Br J Haematol 2021;194:518-29. [PMID: 34114204 DOI: 10.1111/bjh.17664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Atzori L, Recalcati S, Ferreli C, Hoenig L, Rongioletti F. COVID-19–related skin manifestations: Update on therapy. Clinics in Dermatology 2020. [DOI: 10.1016/j.clindermatol.2020.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Queisser KA, Mellema RA, Middleton EA, Portier I, Manne BK, Denorme F, Beswick EJ, Rondina MT, Campbell RA, Petrey AC. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight 2021:147472. [PMID: 34314391 DOI: 10.1172/jci.insight.147472] [Reference Citation Analysis]
34 Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis 2021;322:39-50. [PMID: 33706082 DOI: 10.1016/j.atherosclerosis.2021.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Ricke DO. Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations. JID Innov 2021;:100052. [PMID: 34458884 DOI: 10.1016/j.xjidi.2021.100052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Colmenero I, Santonja C, Alonso-Riaño M, Andina D, Rodríguez Peralto JL, Requena L, Torrelo A. SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions: reply from the authors. Br J Dermatol 2021;184:186-7. [PMID: 33325537 DOI: 10.1111/bjd.19595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Bascuas-Arribas M, Andina-Martinez D, Añon-Hidalgo J, Alonso-Cadenas JA, Hernandez-Martin A, Lamagrande-Casanova N, Noguero-Morel L, Mateos-Mayo A, Colmenero-Blanco I, Torrelo A. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic. Pediatr Dermatol 2022. [PMID: 35129855 DOI: 10.1111/pde.14948] [Reference Citation Analysis]
38 Ko CJ, Harigopal M, Damsky W, Gehlhausen JR, Bosenberg M, Patrignelli R, McNiff JM. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. J Cutan Pathol 2020;47:997-1002. [PMID: 32745281 DOI: 10.1111/cup.13830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
39 Vassallo C, Boveri E, Brazzelli V, Rampino T, Bruno R, Bonometti A, Gregorini M. Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine. Dermatol Ther 2021;:e15076. [PMID: 34327795 DOI: 10.1111/dth.15076] [Reference Citation Analysis]
40 Gehlhausen JR, Little AJ, Ko CJ, Emmenegger M, Lucas C, Wong P, Klein J, Lu P, Mao T, Jaycox J, Wang E, Ugwu N, Muenker C, Mekael D, Klein RQ, Patrignelli R, Antaya R, McNiff J, Damsky W, Kamath K, Shon J, Ring AM, Yildirim I, Omer S, Ko AI, Aguzzi A, Iwasaki A; Yale IMPACT Team. Lack of association between pandemic chilblains and SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2022;119:e2122090119. [PMID: 35217624 DOI: 10.1073/pnas.2122090119] [Reference Citation Analysis]
41 Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 2020;3:100073. [PMID: 33263103 DOI: 10.1016/j.jtauto.2020.100073] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
42 Daneshjou R, Rana J, Dickman M, Yost JM, Chiou A, Ko J. Pernio-like eruption associated with COVID-19 in skin of color. JAAD Case Rep 2020;6:892-7. [PMID: 32835046 DOI: 10.1016/j.jdcr.2020.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
43 Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 2021;164:69-82. [PMID: 34838588 DOI: 10.1016/j.yjmcc.2021.11.010] [Reference Citation Analysis]
44 Trinity JD, Craig JC, Fermoyle CC, McKenzie AI, Lewis MT, Park SH, Rondina MT, Richardson RS. Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study. J Appl Physiol (1985) 2021;130:1961-70. [PMID: 34002634 DOI: 10.1152/japplphysiol.00236.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Jones OY, Yeralan S. Is Long COVID a State of Systemic Pericyte Disarray? JCM 2022;11:572. [DOI: 10.3390/jcm11030572] [Reference Citation Analysis]
46 Nogueira López J, Grasa Lozano C, Ots Ruiz C, Alonso García L, Falces-Romero I, Calvo C, García-López Hortelano M; Grupo de Trabajo de SARS-CoV-2 del Servicio dePediatría del Hospital Universitario La Paz. Telemedicine follow-ups for COVID-19: Experience in a tertiary hospital. An Pediatr (Engl Ed) 2021;95:336-44. [PMID: 34649834 DOI: 10.1016/j.anpede.2020.10.007] [Reference Citation Analysis]
47 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. International Immunopharmacology 2021;101:108217. [DOI: 10.1016/j.intimp.2021.108217] [Reference Citation Analysis]
48 Ramos SG, Rattis BADC, Ottaviani G, Celes MRN, Dias EP. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am J Pathol 2021;191:1154-64. [PMID: 33964216 DOI: 10.1016/j.ajpath.2021.04.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Farhadian SF, Seilhean D, Spudich S. Neuropathogenesis of acute coronavirus disease 2019. Curr Opin Neurol 2021;34:417-22. [PMID: 33852526 DOI: 10.1097/WCO.0000000000000944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Oumarou Hama H, Aboudharam G, Barbieri R, Lepidi H, Drancourt M. Immunohistochemical diagnosis of human infectious diseases: a review. Diagn Pathol 2022;17. [DOI: 10.1186/s13000-022-01197-5] [Reference Citation Analysis]
51 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
52 Neale H, Hawryluk EB. COVID-19 Pediatric Dermatology. Dermatol Clin 2021;39:505-19. [PMID: 34556241 DOI: 10.1016/j.det.2021.05.012] [Reference Citation Analysis]
53 . COVID-19 cutaneous manifestations: simplifying the confusion. Int J Dermatol 2021;60:3-4. [PMID: 33156536 DOI: 10.1111/ijd.15281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Giordo R, Paliogiannis P, Mangoni AA, Pintus G. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vasc Biol 2021;3:R15-23. [PMID: 33659858 DOI: 10.1530/VB-20-0017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
55 Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol 2021;39:149-62. [PMID: 33972045 DOI: 10.1016/j.clindermatol.2020.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
56 Shakshouk H, Johnson EF, Peters MS, Wieland CN, Comfere NI, Lehman JS. Cutaneous eccrine inflammation and necrosis: review of inflammatory disorders affecting the eccrine apparatus including new associations. Hum Pathol 2021:S0046-8177(21)00146-5. [PMID: 34450084 DOI: 10.1016/j.humpath.2021.08.005] [Reference Citation Analysis]
57 Çakmak F, Demirbuga A, Demirkol D, Gümüş S, Torun SH, Kayaalp GK, Ömeroglu RE, Somer A, Uysalol M, Yıldız R, Ayaz NA. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc Res 2021;138:104196. [PMID: 34097919 DOI: 10.1016/j.mvr.2021.104196] [Reference Citation Analysis]
58 Feito-Rodríguez M, Mayor-Ibarguren A, Cámara-Hijón C, Montero-Vega D, Servera-Negre G, Ruiz-Bravo E, Nozal P, Rodríguez-Peralto JL, Enguita AB, Bravo-Gallego LY, Granados-Fernández M, Fernández-Alcalde C, Fernández-Heredero Á, Alonso-Riaño M, Jiménez-Yuste V, Nuño-González A, De Lucas-Laguna R, López-Granados E, Herranz-Pinto P. Chilblain-like lesions and COVID-19 infection: A prospective observational study at Spain's ground zero. J Am Acad Dermatol 2021;84:507-9. [PMID: 33022305 DOI: 10.1016/j.jaad.2020.09.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol 2021;101:108217. [PMID: 34627083 DOI: 10.1016/j.intimp.2021.108217] [Reference Citation Analysis]
60 Neil D, Moran L, Horsfield C, Curtis E, Swann O, Barclay W, Hanley B, Hollinshead M, Roufosse C. Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep. J Pathol 2020;252:346-57. [PMID: 32918747 DOI: 10.1002/path.5547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
61 Bullock HA, Goldsmith CS, Zaki SR, Martines RB, Miller SE. Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy. Emerg Infect Dis 2021;27:1023-31. [PMID: 33600302 DOI: 10.3201/eid2704.204337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
62 Barrera-Godínez A, Méndez-Flores S, Gatica-Torres M, Rosales-Sotomayor A, Campos-Jiménez KI, Carrillo-Córdova DM, Durand-Muñoz MC, Mena-Hernández GL, Melchor-Mendoza YK, Ruelas-Villavicencio AL, García-Irigoyen A, Acatitla-Acevedo GA, Toussaint-Caire S, Domínguez-Cherit J. Not all that glitters is COVID-19: a case series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection. J Eur Acad Dermatol Venereol 2021;35:1865-73. [PMID: 34013600 DOI: 10.1111/jdv.17381] [Reference Citation Analysis]
63 Flores-Pliego A, Miranda J, Vega-Torreblanca S, Valdespino-Vázquez Y, Helguera-Repetto C, Espejel-Nuñez A, Borboa-Olivares H, Espino Y Sosa S, Mateu-Rogell P, León-Juárez M, Ramírez-Santes V, Cardona-Pérez A, Villegas-Mota I, Torres-Torres J, Juárez-Reyes Á, Rizo-Pica T, González RO, González-Mariscal L, Estrada-Gutierrez G. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19. Cells 2021;10:364. [PMID: 33578631 DOI: 10.3390/cells10020364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Yang MS, Oh BK, Yang D, Oh EY, Kim Y, Kang KW, Lim CW, Koh GY, Lee SM, Kim B. Ultra- and micro-structural changes of respiratory tracts in SARS-CoV-2 infected Syrian hamsters. Vet Res 2021;52:121. [PMID: 34530902 DOI: 10.1186/s13567-021-00988-w] [Reference Citation Analysis]
65 Vesely MD, Perkins SH. Caution in the time of rashes and COVID-19. J Am Acad Dermatol 2020;83:e321-2. [PMID: 32682026 DOI: 10.1016/j.jaad.2020.07.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
66 Schwartz M. MIS-C: post-infectious syndrome or persistent infection? Lancet Infect Dis 2021;21:e116. [PMID: 33031752 DOI: 10.1016/S1473-3099(20)30786-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Wahezi DM, Peskin M, Tanner T. The impact of the COVID-19 pandemic on the field of pediatric rheumatology. Curr Opin Rheumatol 2021;33:446-52. [PMID: 34175864 DOI: 10.1097/BOR.0000000000000814] [Reference Citation Analysis]
68 Sachdeva M, Mufti A, Maliyar K, Lara-Corrales I, Salcido R, Sibbald C. A Review of COVID-19 Chilblains-like Lesions and Their Differential Diagnoses. Adv Skin Wound Care 2021;34:348-54. [PMID: 34125725 DOI: 10.1097/01.ASW.0000752692.72055.74] [Reference Citation Analysis]
69 Odilov A, Volkov A, Abdullaev A, Gasanova T, Lipina T, Babichenko I. COVID-19: Multiorgan Dissemination of SARS-CoV-2 Is Driven by Pulmonary Factors. Viruses 2021;14:39. [PMID: 35062243 DOI: 10.3390/v14010039] [Reference Citation Analysis]
70 Piccolo V, Bassi A, Argenziano G, Mazzatenta C, Guglielmo A, Patrizi A, Neri I. Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients. J Am Acad Dermatol 2020;83:1749-51. [PMID: 33010953 DOI: 10.1016/j.jaad.2020.07.058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
71 Monte-Serrano J, García-Gil MF, García-García M, Casas-Flecha I, Matovelle-Ochoa C, Ara-Martín M. Granuloma annulare triggered by SARS-CoV-2 infection: Immunohistochemical staining. Dermatol Ther 2021;34:e14897. [PMID: 33599069 DOI: 10.1111/dth.14897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Cordel N, Grotta G, Guyomard S, Herrmann-Storck C. Viral exanthema in the Americas during the SARS-CoV-2 pandemic infection: dengue or COVID-19? Int J Dermatol 2021;60:751-3. [PMID: 33521958 DOI: 10.1111/ijd.15421] [Reference Citation Analysis]
73 Aslam M, Ladilov Y. Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection. Cells 2020;9:E1962. [PMID: 32854430 DOI: 10.3390/cells9091962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
74 Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, Olinic DM, Farkas K, Elalamy I, Falanga A, Fareed J, Papageorgiou C, Arellano RS, Agathagelou P, Antic D, Auad L, Banfic L, Bartolomew JR, Benczur B, Bernardo MB, Boccardo F, Cifkova R, Cosmi B, De Marchi S, Dimakakos E, Dimopoulos MA, Dimitrov G, Durand-Zaleski I, Edmonds M, El Nazar EA, Erer D, Esponda OL, Gresele P, Gschwandtner M, Gu Y, Heinzmann M, Hamburg NM, Hamadé A, Jatoi NA, Karahan O, Karetova D, Karplus T, Klein-Weigel P, Kolossvary E, Kozak M, Lefkou E, Lessiani G, Liew A, Marcoccia A, Marshang P, Marakomichelakis G, Matuska J, Moraglia L, Pillon S, Poredos P, Prior M, Salvador DRK, Schlager O, Schernthaner G, Sieron A, Spaak J, Spyropoulos A, Sprynger M, Suput D, Stanek A, Stvrtinova V, Szuba A, Tafur A, Vandreden P, Vardas PE, Vasic D, Vikkula M, Wennberg P, Zhai Z; Scientific Reviewer Committee. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020;120:1597-628. [PMID: 32920811 DOI: 10.1055/s-0040-1715798] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
75 Ganatra B, Amarnani R, Alfallouji Y, Dear K, Twigg E, Westwood JP, Goulden B, Morris V, Hillman T, Goolamali S, Naderi Z, Sidwell R, Ellery P, Calonje E, Kravvas G, Bunker CB. Patient characteristics in tardive COVID-19 pseudoperniosis: a case series of 16 patients. Clin Exp Dermatol 2021. [PMID: 34411313 DOI: 10.1111/ced.14891] [Reference Citation Analysis]
76 Uversky VN, Elrashdy F, Aljadawi A, Ali SM, Khan RH, Redwan EM. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? J Neurosci Res 2021;99:750-77. [PMID: 33217763 DOI: 10.1002/jnr.24752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
77 Sodeifian F, Mushtaq S, Rezaei N. Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic? Actas Dermosifiliogr 2021. [PMID: 34866636 DOI: 10.1016/j.adengl.2021.11.033] [Reference Citation Analysis]
78 Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V. Arginine and Endothelial Function. Biomedicines 2020;8:E277. [PMID: 32781796 DOI: 10.3390/biomedicines8080277] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
79 Gallman AE, Fassett MS. Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease. Dermatol Clin 2021;39:533-43. [PMID: 34556243 DOI: 10.1016/j.det.2021.05.008] [Reference Citation Analysis]
80 Wenzel J, Lampe J, Müller-Fielitz H, Schuster R, Zille M, Müller K, Krohn M, Körbelin J, Zhang L, Özorhan Ü, Neve V, Wagner JUG, Bojkova D, Shumliakivska M, Jiang Y, Fähnrich A, Ott F, Sencio V, Robil C, Pfefferle S, Sauve F, Coêlho CFF, Franz J, Spiecker F, Lembrich B, Binder S, Feller N, König P, Busch H, Collin L, Villaseñor R, Jöhren O, Altmeppen HC, Pasparakis M, Dimmeler S, Cinatl J, Püschel K, Zelic M, Ofengeim D, Stadelmann C, Trottein F, Nogueiras R, Hilgenfeld R, Glatzel M, Prevot V, Schwaninger M. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 2021;24:1522-33. [PMID: 34675436 DOI: 10.1038/s41593-021-00926-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
81 Rios CI, Cassatt DR, Hollingsworth BA, Satyamitra MM, Tadesse YS, Taliaferro LP, Winters TA, DiCarlo AL. Commonalities Between COVID-19 and Radiation Injury. Radiat Res 2021;195:1-24. [PMID: 33064832 DOI: 10.1667/RADE-20-00188.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
82 Tamai M, Sakamoto R, Goto N, Morimura O, Nishida T, Iwahashi H, Yokomi A. Cutaneous manifestations of coronavirus disease 2019 patients in Japan. J Dermatol 2022. [PMID: 35535659 DOI: 10.1111/1346-8138.16433] [Reference Citation Analysis]
83 Mawhirt SL, Frankel D, Diaz AM. Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers. Curr Allergy Asthma Rep 2020;20:75. [PMID: 33047260 DOI: 10.1007/s11882-020-00974-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
84 Tong M, Zheng Q, Zhu Y. Reply to Li et al. J Infect Dis 2021;223:179-80. [PMID: 33049030 DOI: 10.1093/infdis/jiaa643] [Reference Citation Analysis]
85 Zacharias H, Dubey S, Koduri G, D'Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev 2021;20:102883. [PMID: 34237419 DOI: 10.1016/j.autrev.2021.102883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Burke KT, Mcginnis KS, Petronic-rosic V. COVID Toes. Clinics in Dermatology 2020. [DOI: 10.1016/j.clindermatol.2020.12.002] [Reference Citation Analysis]
87 Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child 2020:archdischild-2020-320338. [PMID: 33262177 DOI: 10.1136/archdischild-2020-320338] [Cited by in Crossref: 50] [Cited by in F6Publishing: 61] [Article Influence: 25.0] [Reference Citation Analysis]
88 De Greef A, Coulie PG, Baeck M. Pandemic chilblains: Are they SARS-CoV-2-related or not? Clin Immunol 2022;237:108984. [PMID: 35338000 DOI: 10.1016/j.clim.2022.108984] [Reference Citation Analysis]
89 Baeck M, Herman A. COVID toes: where do we stand with the current evidence? Int J Infect Dis 2021;102:53-5. [PMID: 33075530 DOI: 10.1016/j.ijid.2020.10.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
90 Sanghvi AR. COVID-19: An overview for dermatologists. Int J Dermatol 2020;59:1437-49. [PMID: 33107038 DOI: 10.1111/ijd.15257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
91 Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article. Dermatol Ther 2021;34:e14554. [PMID: 33210417 DOI: 10.1111/dth.14554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
92 Koschitzky M, Oyola RR, Lee-Wong M, Abittan B, Silverberg N. Pediatric COVID toes and fingers. Clin Dermatol 2021;39:84-91. [PMID: 33972057 DOI: 10.1016/j.clindermatol.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Leoni E, Cerati M, Finzi G, Lombardo M, Sessa F. COVID-19 and HHV8 first spotted together: an affair under electron microscopy. J Eur Acad Dermatol Venereol 2021;35:e311-2. [PMID: 33460479 DOI: 10.1111/jdv.17123] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
94 Colmenero I, Santonja C, Alonso-Riaño M, Andina D, Rodríguez-Peralto JL, Requena L, Torrelo A. Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned. Reply from the authors. Br J Dermatol 2020;183:1153-4. [PMID: 32798316 DOI: 10.1111/bjd.19491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Sadeghzadeh-Bazargan A, Rezai M, Najar Nobari N, Mozafarpoor S, Goodarzi A. Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients. J Cutan Pathol 2021. [PMID: 33978234 DOI: 10.1111/cup.14059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
96 Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, Weber C, Bochaton-Piallat ML, Bäck M. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020;116:2177-84. [PMID: 32750108 DOI: 10.1093/cvr/cvaa230] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 44.5] [Reference Citation Analysis]
97 Xu Q, Chen L, Li X, Zheng J. If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19. J Am Acad Dermatol 2021;84:e173. [PMID: 33159988 DOI: 10.1016/j.jaad.2020.10.084] [Reference Citation Analysis]
98 Andina-Martinez D, Nieto-Moro M, Alonso-Cadenas JA, Añon-Hidalgo J, Hernandez-Martin A, Perez-Suarez E, Colmenero-Blanco I, Iglesias-Bouza MI, Cano-Fernandez J, Mateos-Mayo A, Torrelo A. Mucocutaneous manifestations in children hospitalized with COVID-19. J Am Acad Dermatol 2021;85:88-94. [PMID: 33819537 DOI: 10.1016/j.jaad.2021.03.083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
99 Farinazzo E, Dianzani C, Zalaudek I, Conforti C, Grabbe S, Goldust M. Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes. Clin Cosmet Investig Dermatol 2021;14:991-7. [PMID: 34385830 DOI: 10.2147/CCID.S325552] [Reference Citation Analysis]
100 Scigliano G, Scigliano GA. Methylene blue in covid-19. Med Hypotheses 2021;146:110455. [PMID: 33341032 DOI: 10.1016/j.mehy.2020.110455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
101 Pilkington SM, Watson REB. Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19? Br J Dermatol 2021. [PMID: 34748213 DOI: 10.1111/bjd.20784] [Reference Citation Analysis]
102 Xu Q, Zhang L, Chen L, Zhao X, Wang X, Hu M, Le Y, Xue F, Li X, Zheng J. SARS-CoV-2 might transmit through the skin while the skin barrier function could be the mediator. Med Hypotheses 2022;159:110752. [PMID: 35002019 DOI: 10.1016/j.mehy.2021.110752] [Reference Citation Analysis]
103 Brancaccio G, Gussetti N, Sasset L, Alaibac M, Tarantello M, Salmaso R, Trevenzoli M, Cattelan AM. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions. Pathog Glob Health 2021;:1-4. [PMID: 33729097 DOI: 10.1080/20477724.2021.1901040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 García-Gil MF, Monte-Serrano J, Lapeña-Casado A, Villagrasa-Boli P, Ramírez-Lluch M, Martínez-Pallás I, Bularca A, Aldea-Manrique B, Benito-Ruesca R, Ventura-Faci MP, Ara-Martín M. No antibody response in cutaneous manifestations associated with COVID-19: An observational study of 64 cases with microbiological and clinical characterization. Dermatol Ther 2021;:e15142. [PMID: 34549491 DOI: 10.1111/dth.15142] [Reference Citation Analysis]
105 Swali RN, Lee EB, Adams JL. Gianotti-crosti syndrome in the setting of recent coronavirus disease-19 infection. Pediatr Dermatol 2021;38:629-31. [PMID: 33641205 DOI: 10.1111/pde.14518] [Reference Citation Analysis]
106 Das S. Microcirculatory changes and thrombotic complications in COVID-19. Br J Community Nurs 2021;26:474-80. [PMID: 34632792 DOI: 10.12968/bjcn.2021.26.10.474] [Reference Citation Analysis]
107 Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, Carrera C, Andreu-Febrer C, Sanz-Beltran J, Riquelme-Mc Loughlin C, Riera-Monroig J, Combalia A, Bosch-Amate X, Morgado-Carrasco D, Pigem R, Toll-Abelló A, Martí-Martí I, Rizo-Potau D, Serra-García L, Alamon-Reig F, Iranzo P, Almuedo-Riera A, Muñoz J, Puig S, Mascaró JM Jr. Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity. J Clin Med 2020;9:E3261. [PMID: 33053817 DOI: 10.3390/jcm9103261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
108 Baeck M, Hoton D, Marot L, Herman A. Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned. Br J Dermatol 2020;183:1152-3. [PMID: 32798309 DOI: 10.1111/bjd.19489] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
109 Andina Martínez D, Vinagre Enríquez S, Molina Cabañero JC. [Palmar pulpitis as an isolated expression of SARS-CoV-2 infection]. Aten Primaria 2021;53:101955. [PMID: 33384194 DOI: 10.1016/j.aprim.2020.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Evans P, Wojta J, Hoefer IE, Waltenberger J, Guzik T, Badimon L, Weber C. The year in basic vascular biology research: from mechanoreceptors and neutrophil extracellular traps to smartphone data and omics. Cardiovasc Res 2021;117:1814-22. [PMID: 33744925 DOI: 10.1093/cvr/cvab105] [Reference Citation Analysis]
111 Goyal A, Prasad R, Goel P, Pal A, Prasad S, Rani I. An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy. Indian J Clin Biochem 2021;:1-17. [PMID: 33875909 DOI: 10.1007/s12291-021-00972-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
112 Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A, Elangovan A, Malik YS. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Health 2021;10:100694. [PMID: 33462564 DOI: 10.1016/j.cegh.2020.100694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
113 Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol 2021;46:462-72. [PMID: 33207021 DOI: 10.1111/ced.14483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
114 Oliva Rodríguez-Pastor S, Martín Pedraz L, Carazo Gallego B, Galindo Zavala R, Lozano Sánchez G, de Toro Peinado I, Rodriguez Benjumea M, Mejias A, Núñez Cuadros E. Skin manifestations during the COVID-19 pandemic in the pediatric emergency department. Pediatr Int 2021;63:1033-7. [PMID: 33278056 DOI: 10.1111/ped.14568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Patrick MT, Zhang H, Wasikowski R, Prens EP, Weidinger S, Gudjonsson JE, Elder JT, He K, Tsoi LC. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol 2021;147:857-869.e7. [PMID: 33485957 DOI: 10.1016/j.jaci.2021.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
116 Iraji F, Galehdari H, Siadat AH, Bokaei Jazi S. Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection: A case report. Clin Case Rep 2021;9:830-4. [PMID: 33598253 DOI: 10.1002/ccr3.3596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
117 Latreille E, Lee WL. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses. 2021;13. [PMID: 33499234 DOI: 10.3390/v13020161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
118 Willyard C. Are 'COVID toes' actually caused by the coronavirus? Nature 2022. [PMID: 35296839 DOI: 10.1038/d41586-022-00707-1] [Reference Citation Analysis]
119 Bassi A, Russo T, Argenziano G, Mazzatenta C, Venturini E, Neri I, Piccolo V. Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art. Life (Basel) 2021;11:23. [PMID: 33401712 DOI: 10.3390/life11010023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
120 Munn LL, Stylianopoulos T, Jain NK, Hardin CC, Khandekar MJ, Jain RK. Vascular Normalization to Improve Treatment of COVID-19: Lessons from Treatment of Cancer. Clin Cancer Res 2021;27:2706-11. [PMID: 33648989 DOI: 10.1158/1078-0432.CCR-20-4750] [Reference Citation Analysis]
121 El-Hor N, Adams M. Pediatric Rheumatologic Effects of COVID-19. Pediatr Clin North Am 2021;68:1011-27. [PMID: 34538296 DOI: 10.1016/j.pcl.2021.05.002] [Reference Citation Analysis]
122 Kohl S, Eifler L. [A 15-year-old girl with swollen and reddened toes]. Monatsschr Kinderheilkd 2021;:1-4. [PMID: 33903780 DOI: 10.1007/s00112-021-01190-0] [Reference Citation Analysis]
123 Severino P, D'Amato A, Pucci M, Infusino F, Adamo F, Birtolo LI, Netti L, Montefusco G, Chimenti C, Lavalle C, Maestrini V, Mancone M, Chilian WM, Fedele F. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. Int J Mol Sci 2020;21:E8118. [PMID: 33143256 DOI: 10.3390/ijms21218118] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
124 Wagner JUG, Bojkova D, Shumliakivska M, Luxán G, Nicin L, Aslan GS, Milting H, Kandler JD, Dendorfer A, Heumueller AW, Fleming I, Bibli SI, Jakobi T, Dieterich C, Zeiher AM, Ciesek S, Cinatl J, Dimmeler S. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol 2021;116:42. [PMID: 34224022 DOI: 10.1007/s00395-021-00882-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int 2021;41:19-32. [PMID: 33219837 DOI: 10.1007/s00296-020-04749-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 18.0] [Reference Citation Analysis]
126 Al-Gburi S, Beissert S, Günther C. Molecular mechanisms of vasculopathy and coagulopathy in COVID-19. Biol Chem 2021;402:1505-18. [PMID: 34657406 DOI: 10.1515/hsz-2021-0245] [Reference Citation Analysis]
127 Ferjani M, Ben Slimane M, Sayari T, Hammi Y, Litaiem N, Naija O, Zeglaoui F, Gargah T. Infectious-mononucleosis-like exanthema associated with COVID-19 in a child. Clin Case Rep 2021;9:e04481. [PMID: 34322248 DOI: 10.1002/ccr3.4481] [Reference Citation Analysis]
128 Hofman P, Copin MC, Tauziede-Espariat A, Adle-Biassette H, Fortarezza F, Passeron T, Salmon I, Calabrese F. [Histopathological features due to the SARS-CoV-2]. Ann Pathol 2021;41:9-22. [PMID: 33446414 DOI: 10.1016/j.annpat.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Brealey JK, Miller SE. SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions. Br J Dermatol 2021;184:186. [PMID: 33000462 DOI: 10.1111/bjd.19572] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
130 Davido B, Mascitti H, Fortier-Beaulieu M, Jaffal K, de Truchis P. 'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine. J Travel Med 2021;28:taab024. [PMID: 33620081 DOI: 10.1093/jtm/taab024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
131 Andrade FB, Gualberto A, Rezende C, Percegoni N, Gameiro J, Hottz ED. The Weight of Obesity in Immunity from Influenza to COVID-19. Front Cell Infect Microbiol 2021;11:638852. [PMID: 33816341 DOI: 10.3389/fcimb.2021.638852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
132 Ko CJ, Harigopal M, Gehlhausen JR, Bosenberg M, McNiff JM, Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J Cutan Pathol 2021;48:47-52. [PMID: 32895985 DOI: 10.1111/cup.13866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
133 Nogueira López J, Grasa Lozano C, Ots Ruiz C, Alonso García L, Falces-Romero I, Calvo C, García-López Hortelano M; Grupo de Trabajo de SARS-CoV-2 del Servicio de Pediatría del Hospital Universitario La Paz. [Telemedicine follow-ups for COVID-19: Experience in a tertiary hospital]. An Pediatr (Engl Ed) 2020:S1695-4033(20)30476-8. [PMID: 33328150 DOI: 10.1016/j.anpedi.2020.10.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021;9:e14726. [PMID: 33523608 DOI: 10.14814/phy2.14726] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
135 Robustelli Test E, Sena P, Locatelli AG, Carugno A, di Mercurio M, Moggio E, Gambini DM, Arosio MEG, Callegaro A, Morotti D, Gianatti A, Vezzoli P. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study. Pediatr Dermatol 2022. [PMID: 34989043 DOI: 10.1111/pde.14903] [Reference Citation Analysis]
136 Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q, Liu R, Chen W, Tong W, Wei Q, Xu Y, Deng W, Gao H, Xue J, Song Z, Yu P, Han Y, Zhang Y, Sun X, Yu X, Qin C. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther 2021;6:337. [PMID: 34489403 DOI: 10.1038/s41392-021-00719-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Muhammad A, Iftikhar N, Mashhood A, Virdi G, Ud Din H, Akbar A, Ahmad B, Khalid A. Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan. Cureus 2021;13:e18973. [PMID: 34820228 DOI: 10.7759/cureus.18973] [Reference Citation Analysis]
138 Emeršič N, Tomaževič T, Točkova O, Kopač M, Volavšek M, Ključevšek D, Avčin T. Case Report: Necrotizing Stomatitis as a Manifestation of COVID-19-Associated Vasculopathy. Front Pediatr 2021;9:800576. [DOI: 10.3389/fped.2021.800576] [Reference Citation Analysis]
139 Bullock HA, Goldsmith CS, Miller SE. Best practices for correctly identifying coronavirus by transmission electron microscopy. Kidney Int 2021;99:824-7. [PMID: 33493525 DOI: 10.1016/j.kint.2021.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
140 Lopez S, Vakharia P, Vandergriff T, Freeman EE, Vasquez R. Pernio after COVID-19 vaccination. Br J Dermatol 2021;185:445-7. [PMID: 33893637 DOI: 10.1111/bjd.20404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
141 Ma Z, Li X, Fan RLY, Yang KY, Ng CSH, Lau RWH, Wong RHL, Ng KK, Wang CC, Ye P, Fu Z, Chin AWH, Lai MYA, Huang Y, Tian XY, Poon LLM, Lui KO. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Reports 2022:S2213-6711(22)00059-5. [PMID: 35180397 DOI: 10.1016/j.stemcr.2022.01.015] [Reference Citation Analysis]
142 Haslak F, Yıldız M, Adrovic A, Şahin S, Barut K, Kasapçopur Ö. A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C). Turk Arch Pediatr 2021;56:3-9. [PMID: 34013222 DOI: 10.5152/TurkArchPediatr.2020.20245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
143 Camprodon Gómez M, González-Cruz C, Ferrer B, Barberá MJ. Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy. BMJ Case Rep 2020;13:e238039. [PMID: 33122236 DOI: 10.1136/bcr-2020-238039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
144 Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells 2021;10:3592. [PMID: 34944099 DOI: 10.3390/cells10123592] [Reference Citation Analysis]
145 Beato Merino MJ, Diago A, Fernández-Flores Á, Fraga J, García Herrera A, Garrido M, Idoate Gastearena MÁ, Llamas-Velasco M, Monteagudo C, Onrubia J, Pérez-González YC, Pérez Muñoz N, Ríos-Martín JJ, Ríos-Viñuela E, Rodríguez Peralto JL, Rozas Muñoz E, Sanmartín O, Santonja C, Santos-Briz Á, Saus C, Suárez Peñaranda JM, Velasco Benito V. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occlusion - Part I: Thrombi. Actas Dermosifiliogr (Engl Ed) 2021;112:1-13. [PMID: 33045208 DOI: 10.1016/j.ad.2020.09.006] [Reference Citation Analysis]
146 Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, Docampo-Simón A, Belinchón-Romero I, Ramos-Rincón JM. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2022;36:24-38. [PMID: 34545625 DOI: 10.1111/jdv.17672] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Frumholtz L, Bouaziz JD, Battistella M, Hadjadj J, Chocron R, Bengoufa D, Le Buanec H, Barnabei L, Meynier S, Schwartz O, Grzelak L, Smith N, Charbit B, Duffy D, Yatim N, Calugareanu A, Philippe A, Guerin CL, Joly B, Siguret V, Jaume L, Bachelez H, Bagot M, Rieux-Laucat F, Maylin S, Legoff J, Delaugerre C, Gendron N, Smadja DM, Cassius C; Saint-Louis CORE (COvid REsearch). Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak. Br J Dermatol 2021. [PMID: 34611893 DOI: 10.1111/bjd.20707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Reiff DD, Meyer CG, Marlin B, Mannion ML. New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report. BMC Pediatr 2021;21:333. [PMID: 34353302 DOI: 10.1186/s12887-021-02812-y] [Reference Citation Analysis]
149 Promenzio L, Arcangeli F, Cortis E, Sama E, Longhini F. Erythema Pernio-Like in Four Adolescents in the Era of the Coronavirus-2 Infection. Rev Recent Clin Trials 2021;16:216-9. [PMID: 33069200 DOI: 10.2174/1574887115666201016153031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
150 Zaffanello M, Piacentini G, Nosetti L, Ganzarolli S, Franchini M. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature. Thromb Res 2021;205:92-8. [PMID: 34293539 DOI: 10.1016/j.thromres.2021.07.011] [Reference Citation Analysis]
151 Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case Rep 2020;6:871-4. [PMID: 32835045 DOI: 10.1016/j.jdcr.2020.07.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
152 Mirza FN, Malik AA, Omer SB, Sethi A. Dermatologic manifestations of COVID-19: a comprehensive systematic review. Int J Dermatol 2021;60:418-50. [PMID: 33141443 DOI: 10.1111/ijd.15168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
153 Lavery MJ, Bouvier CA, Thompson B. Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate. Clin Dermatol 2021;39:323-8. [PMID: 34272030 DOI: 10.1016/j.clindermatol.2020.10.020] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
154 Jamiolkowski D, Mühleisen B, Müller S, Navarini AA, Tzankov A, Roider E. SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report. Lancet 2020;396:598-9. [PMID: 32798450 DOI: 10.1016/S0140-6736(20)31754-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
155 Cappel MA, Cappel JA, Wetter DA. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. Mayo Clin Proc 2021;96:989-1005. [PMID: 33714595 DOI: 10.1016/j.mayocp.2021.01.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
156 Cazzato G, Mazzia G, Cimmino A, Colagrande A, Sablone S, Lettini T, Rossi R, Santarella N, Elia R, Nacchiero E, Maruccia M, Marzullo A, Maiorano E, Giudice G, Ingravallo G, Resta L. SARS-CoV-2 and Skin: The Pathologist's Point of View. Biomolecules 2021;11:838. [PMID: 34200112 DOI: 10.3390/biom11060838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
157 Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2020;13:E29. [PMID: 33375371 DOI: 10.3390/v13010029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
158 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Reference Citation Analysis]
159 Occidental M, Flaifel A, Lin LH, Guzzetta M, Thomas K, Jour G. Investigating the spectrum of dermatologic manifestations in COVID-19 infection in severely ill patients: A series of four cases. J Cutan Pathol 2021;48:110-5. [PMID: 32896915 DOI: 10.1111/cup.13867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
160 Bessis D. Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window. Br J Dermatol 2021;184:11-2. [PMID: 33249567 DOI: 10.1111/bjd.19596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, Chamberlin G, Fathy R, Nazarian RM, Desai SR, Lim HW, Thiers BH, Hruza GJ, French LE, Blumenthal K, Fox LP, Freeman EE. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am Acad Dermatol 2021:S0190-9622(21)02442-7. [PMID: 34517079 DOI: 10.1016/j.jaad.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Gawaz A, Guenova E. Microvascular Skin Manifestations Caused by COVID-19. Hamostaseologie 2021;41:387-96. [PMID: 34695855 DOI: 10.1055/a-1581-6899] [Reference Citation Analysis]
163 van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, Kolundzic N, Abdulle AE, van der Voort PH, Olde Rikkert MG, van der Hoeven JG, den Dunnen WF, Hillebrands JL, van Goor H. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol 2021;254:307-31. [PMID: 33586189 DOI: 10.1002/path.5642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
164 Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021;20:102899. [PMID: 34274540 DOI: 10.1016/j.autrev.2021.102899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
165 Mohanty SK, Satapathy A, Naidu MM, Mukhopadhyay S, Sharma S, Barton LM, Stroberg E, Duval EJ, Pradhan D, Tzankov A, Parwani AV. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge. Diagn Pathol 2020;15:103. [PMID: 32799894 DOI: 10.1186/s13000-020-01017-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 16.5] [Reference Citation Analysis]
166 Akilesh S, Nicosia RF, Alpers CE, Tretiakova M, Hsiang TY, Gale M Jr, Smith KD. Characterizing Viral Infection by Electron Microscopy: Lessons from the Coronavirus Disease 2019 Pandemic. Am J Pathol 2021;191:222-7. [PMID: 33227297 DOI: 10.1016/j.ajpath.2020.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
167 Liu F, Han K, Blair R, Kenst K, Qin Z, Upcin B, Wörsdörfer P, Midkiff CC, Mudd J, Belyaeva E, Milligan NS, Rorison TD, Wagner N, Bodem J, Dölken L, Aktas BH, Vander Heide RS, Yin XM, Kolls JK, Roy CJ, Rappaport J, Ergün S, Qin X. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro. Front Cell Infect Microbiol 2021;11:701278. [PMID: 34307198 DOI: 10.3389/fcimb.2021.701278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
168 Hubiche T, Phan A, Leducq S, Rapp J, Fertitta L, Aubert H, Barbarot S, Chiaverini C, Giraudeau B, Lasek A, Mallet S, Labarelle A, Piram M, McCuaig C, Martin L, Monitor L, Nicol I, Bissuel M, Bellissen A, Jullien D, Lesort C, Vabres P, Maruani A; Research Group of the Société Française de Dermatologie Pédiatrique (French Society of Pediatric Dermatology). Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clusters. Ann Dermatol Venereol 2021;148:94-100. [PMID: 33551211 DOI: 10.1016/j.annder.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, Razani B, Mwangi J, Asadi-Pooya AA, Malekmakan L, Bastani B. Long COVID, a comprehensive systematic scoping review. Infection 2021. [PMID: 34319569 DOI: 10.1007/s15010-021-01666-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
170 Smith KD, Akilesh S. Pathogenesis of coronavirus disease 2019-associated kidney injury. Curr Opin Nephrol Hypertens 2021;30:324-31. [PMID: 33767060 DOI: 10.1097/MNH.0000000000000708] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Giraud-Kerleroux L, Mongereau M, Cassius C, Mrad M, Gary C, Fiani C, Ben Kahla M, Mahevas T, Zuelgaray E, Skayem C, Hua C, Ezzedine K, Bagot M, Bouaziz JD, Duong TA. Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology. J Eur Acad Dermatol Venereol 2021;35:e556-8. [PMID: 34014574 DOI: 10.1111/jdv.17378] [Reference Citation Analysis]
172 Perisé-Barrios AJ, Tomeo-Martín BD, Gómez-Ochoa P, Delgado-Bonet P, Plaza P, Palau-Concejo P, González J, Ortiz-Díez G, Meléndez-Lazo A, Gentil M, García-Castro J, Barbero-Fernández A. Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in Spain. Vet Res 2021;52:22. [PMID: 33588935 DOI: 10.1186/s13567-021-00897-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
173 Agnihothri R, Fox LP. Clinical Patterns and Morphology of COVID-19 Dermatology. Dermatol Clin 2021;39:487-503. [PMID: 34556240 DOI: 10.1016/j.det.2021.05.006] [Reference Citation Analysis]
174 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
175 Sodeifian F, Mushtaq S, Rezaei N. [Cutaneous Manifestation of COVID-19: What have we learned an year into the pandemic?]. Actas Dermosifiliogr (Engl Ed) 2021. [PMID: 34580541 DOI: 10.1016/j.ad.2021.08.005] [Reference Citation Analysis]
176 Khezri MR, Ghasemnejad-Berenji M, Jafari R. Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit? Adv Skin Wound Care 2021;34:513-4. [PMID: 34546200 DOI: 10.1097/01.ASW.0000772732.19325.30] [Reference Citation Analysis]
177 Rosés-Gibert P, Gimeno Castillo J, Saenz Aguirre A, De la Torre Gomar FJ, Carnero González L, Martinez de Lagrán Alvarez de Arcaya Z, Gonzalez-Perez R. Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain. World J Pediatr 2020;16:629-32. [PMID: 32901377 DOI: 10.1007/s12519-020-00390-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
178 Fosse JH, Haraldsen G, Falk K, Edelmann R. Endothelial Cells in Emerging Viral Infections. Front Cardiovasc Med 2021;8:619690. [PMID: 33718448 DOI: 10.3389/fcvm.2021.619690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
179 Gómez-Fernández C, López-Sundh AE, González-Vela C, Ocejo-Vinyals JG, Mayor-Ibarguren A, Salas-Venero CA, Gutiérrez-Larrañaga M, Tejerina-Puente A, Fariñas MC, Cabero-Pérez MJ, López-Hoyos M, González-López MA. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak. Int J Dermatol 2020;59:1475-84. [PMID: 33070314 DOI: 10.1111/ijd.15234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
180 Gao Y, Zhou W, Huang P, Liu H, Bi X, Zhu Y, Sun J, Tang Q, Li L, Zhang J, Zhu W, Cheng X, Liu Y, Deng Y. Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery. Front Med 2022;9:809033. [DOI: 10.3389/fmed.2022.809033] [Reference Citation Analysis]
181 Nägele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis 2020;314:58-62. [PMID: 33161318 DOI: 10.1016/j.atherosclerosis.2020.10.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 24.5] [Reference Citation Analysis]
182 Borcherding L, Teksen AS, Grosser B, Schaller T, Hirschbühl K, Claus R, Spring O, Wittmann M, Römmele C, Sipos É, Märkl B. Impaired Dendritic Cell Homing in COVID-19. Front Med (Lausanne) 2021;8:761372. [PMID: 34805226 DOI: 10.3389/fmed.2021.761372] [Reference Citation Analysis]
183 Hopfer H, Herzig MC, Gosert R, Menter T, Hench J, Tzankov A, Hirsch HH, Miller SE. Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues. Histopathology 2021;78:358-70. [PMID: 32981112 DOI: 10.1111/his.14264] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
184 Fattori A, Cribier B, Chenard MP, Mitcov M, Mayeur S, Weingertner N. Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings. Hum Pathol 2021;107:39-45. [PMID: 33161030 DOI: 10.1016/j.humpath.2020.10.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
185 Burke KT, McGinnis KS, Petronic-Rosic V. COVID toes: Pernio-like lesions. Clin Dermatol 2021;39:380-3. [PMID: 34517996 DOI: 10.1016/j.clindermatol.2021.01.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Fang XZ, Wang YX, Xu JQ, He YJ, Peng ZK, Shang Y. Immunothrombosis in Acute Respiratory Dysfunction of COVID-19. Front Immunol 2021;12:651545. [PMID: 34149692 DOI: 10.3389/fimmu.2021.651545] [Reference Citation Analysis]
187 Pérez-López I, Gil-Villalba A, Ruiz-Villaverde R. Perniosis-like lesions after vaccination with mRNA against COVID-19. Med Clin (Barc) 2021:S0025-7753(21)00324-9. [PMID: 34229882 DOI: 10.1016/j.medcli.2021.05.016] [Reference Citation Analysis]
188 Discepolo V, Catzola A, Pierri L, Mascolo M, Della Casa F, Vastarella M, Smith G, Travaglino A, Punziano A, Nappa P, Staibano S, Bruzzese E, Fabbrocini G, Guarino A, Alessio M. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic. JAMA Netw Open 2021;4:e2111369. [PMID: 34110396 DOI: 10.1001/jamanetworkopen.2021.11369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Benedetti F, Silvestri G, Mavian C, Weichseldorfer M, Munawwar A, Cash MN, Dulcey M, Vittor AY, Ciccozzi M, Salemi M, Latinovic OS, Zella D. Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells. Viruses 2021;13:2193. [PMID: 34834998 DOI: 10.3390/v13112193] [Reference Citation Analysis]
190 Rubin A, Alamgir M, Rubin J, Rao BK. Chilblain-like lesions with prominent bullae in a patient with COVID-19. BMJ Case Rep 2020;13:e237917. [PMID: 33139373 DOI: 10.1136/bcr-2020-237917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
191 Esteve-Sole A, Anton J, Pino-Ramirez RM, Sanchez-Manubens J, Fumadó V, Fortuny C, Rios-Barnes M, Sanchez-de-Toledo J, Girona-Alarcón M, Mosquera JM, Ricart S, Launes C, de Sevilla MF, Jou C, Muñoz-Almagro C, González-Roca E, Vergara A, Carrillo J, Juan M, Cuadras D, Noguera-Julian A, Jordan I, Alsina L. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease. J Clin Invest 2021;131:144554. [PMID: 33497356 DOI: 10.1172/JCI144554] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 16.0] [Reference Citation Analysis]
192 Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol 2021. [PMID: 34077629 DOI: 10.1111/jocd.14266] [Reference Citation Analysis]
193 Aschoff R, Zimmermann N, Beissert S, Günther C. Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic. Dermatopathology (Basel) 2020;7:57-63. [PMID: 33291622 DOI: 10.3390/dermatopathology7030010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
194 Cicco S, Vacca A, Cariddi C, Carella R, Altamura G, Solimando AG, Lauletta G, Pappagallo F, Cirulli A, Stragapede A, Susca N, Grasso S, Ria R. Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19. Diagnostics (Basel) 2021;11:1271. [PMID: 34359355 DOI: 10.3390/diagnostics11071271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Adekiigbe R, Ugbode F, Seoparson S, Katriyar N, Fetterman A. A 47-Year-Old Hispanic Man Who Developed Cutaneous Vasculitic Lesions and Gangrene of the Toes Following Admission to Hospital with COVID-19 Pneumonia. Am J Case Rep 2020;21:e926886. [PMID: 32999267 DOI: 10.12659/AJCR.926886] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
196 Raff LA, Reid TD, Johnson D, Raff EJ, Schneider AB, Charles AG, Gallaher JR. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS. Am J Surg 2021:S0002-9610(21)00233-6. [PMID: 33894980 DOI: 10.1016/j.amjsurg.2021.04.004] [Reference Citation Analysis]
197 Saghafi N, Rezaee SA, Momtazi-Borojeni AA, Tavasolian F, Sathyapalan T, Abdollahi E, Sahebkar A. The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19. Life Sci 2022;:120392. [PMID: 35149115 DOI: 10.1016/j.lfs.2022.120392] [Reference Citation Analysis]
198 Maruhashi T, Higashi Y. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19. Int J Mol Sci 2021;22:5131. [PMID: 34066226 DOI: 10.3390/ijms22105131] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
199 Visconti A, Bataille V, Rossi N, Kluk J, Murphy R, Puig S, Nambi R, Bowyer RCE, Murray B, Bournot A, Wolf J, Ourselin S, Steves CJ, Spector TD, Falchi M. Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection. Br J Dermatol 2021;184:880-7. [PMID: 33448030 DOI: 10.1111/bjd.19807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
200 Rongioletti F. The crucial role of clinicopathological correlation in COVID-19-related cutaneous manifestations. J Eur Acad Dermatol Venereol 2021;35:1742-3. [PMID: 34418883 DOI: 10.1111/jdv.17414] [Reference Citation Analysis]
201 Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun 2021;117:102592. [PMID: 33401171 DOI: 10.1016/j.jaut.2020.102592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
202 Stavert R, Meydani-Korb A, de Leon D, Osgood R, Blau J, Luu T. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic. J Am Acad Dermatol 2020;83:1753-5. [PMID: 32822790 DOI: 10.1016/j.jaad.2020.08.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
203 Kha C, Itkin A. New-onset chilblains in close temporal association to mRNA-1273 vaccination. JAAD Case Rep 2021;12:12-4. [PMID: 33898675 DOI: 10.1016/j.jdcr.2021.03.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
204 Wang X, Yi P, Liang Y. The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19? Front Immunol 2021;12:662266. [PMID: 34054828 DOI: 10.3389/fimmu.2021.662266] [Reference Citation Analysis]
205 Calderón-Garcidueñas L, Torres-Jardón R, Franco-Lira M, Kulesza R, González-Maciel A, Reynoso-Robles R, Brito-Aguilar R, García-Arreola B, Revueltas-Ficachi P, Barrera-Velázquez JA, García-Alonso G, García-Rojas E, Mukherjee PS, Delgado-Chávez R. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution. J Alzheimers Dis 2020;78:479-503. [PMID: 32955466 DOI: 10.3233/JAD-200891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
206 Ionescu MA. COVID-19 skin lesions are rarely positive at RT-PCR test: the macrophage activation with vascular impact and SARS-CoV-2-induced cytokine storm. Int J Dermatol 2021. [PMID: 34213786 DOI: 10.1111/ijd.15749] [Reference Citation Analysis]
207 Ingravallo G, Mazzotta F, Resta L, Sablone S, Cazzato G, Cimmino A, Rossi R, Colagrande A, Ferrante B, Troccoli T, Bonifazi E. Inflammatory Skin Lesions in Three SARS-CoV-2 Swab-Negative Adolescents: A Possible COVID-19 Sneaky Manifestation? Pediatr Rep 2021;13:181-8. [PMID: 33918585 DOI: 10.3390/pediatric13020025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
208 Magro C, Nuovo G, Mulvey JJ, Laurence J, Harp J, Crowson AN. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Clinics in Dermatology 2021;39:934-65. [DOI: 10.1016/j.clindermatol.2021.07.001] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Riedel C, Rivera JC, Canedo-Marroquín G, Kalergis AM, Opazo MC. Respiratory viral infections during pregnancy: effects of SARS-CoV-2 and other related viruses over the offspring. J Dev Orig Health Dis 2021;:1-6. [PMID: 33526164 DOI: 10.1017/S2040174420001373] [Reference Citation Analysis]
210 Dinulos JE, Dinulos JG. Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. Curr Opin Pediatr 2021;33:691-703. [PMID: 34670262 DOI: 10.1097/MOP.0000000000001076] [Reference Citation Analysis]
211 Yamada S, Asakura H. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. IJMS 2022;23:3338. [DOI: 10.3390/ijms23063338] [Reference Citation Analysis]
212 Maanaoui S, Salez F, Carpentier O. Recurrence of chilblains during a second contact with SARS-CoV-2: a case report. Br J Dermatol 2021;185:227-8. [PMID: 33733452 DOI: 10.1111/bjd.20070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ, Blumenthal KG, Fox LP, Freeman EE. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol 2021;85:46-55. [PMID: 33838206 DOI: 10.1016/j.jaad.2021.03.092] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 72.0] [Reference Citation Analysis]
214 Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis 2020;50:499-511. [PMID: 32700024 DOI: 10.1007/s11239-020-02230-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 38.5] [Reference Citation Analysis]
215 Seque CA, Enokihara MMSES, Porro AM, Tomimori J. Skin manifestations associated with COVID-19. An Bras Dermatol 2021:S0365-0596(21)00277-4. [PMID: 34857407 DOI: 10.1016/j.abd.2021.08.002] [Reference Citation Analysis]
216 Arkin LM, Moon JJ, Tran JM, Asgari S, O'Farrelly C, Casanova JL, Cowen EW, Mays JW, Singh AM, Drolet BA; COVID Human Genetic Effort. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio. J Invest Dermatol 2021;141:2791-6. [PMID: 34561087 DOI: 10.1016/j.jid.2021.05.024] [Reference Citation Analysis]